Coagulation Analyzers Market Worth $3.58 Billion by 2019

DALLAS, March 20, 2015 /PRNewswire/ --

According to a new market research report "Coagulation/Hemostasis Analyzer Market By product (Automated, POC), Consumables (Reagents, Standards), Test Type (APTT, Prothrombin Time/INR, D-Dimer, Fibrinogen), Technology (Mechanical, Optical), End Users (Research Institute, Hospital)-Forecast to 2019", published by MarketsandMarkets, the Coagulation Analyzers Market is expected to reach around $3.58 Billion by 2019 with a CAGR of 8.3%% during the forecast period 2014 to 2019.

Browse210market data tables and19figures spread through280pages and in-depth TOC on "Coagulation Analyzers Market"

http://www.marketsandmarkets.com/Market-Reports/hemostasis-coagulation-analyzer-market-197226392.html

Early buyers will receive 10% customization on this report.

The Global Coagulation Analyzers Market is expected to reach $3.58 Billion by 2019 from $2.4 Billion in 2014, growing at a CAGR of 8.3% from 2014 to 2019.

The report segments the Coagulation Analyzers Market based on the type of product, test type, technology, end user, and geography. Among Product type clinical laboratory segment accounted for the largest share in 2014. In addition to this, among clinical laboratory segment, the consumables segment is expected to account for the largest share in 2014. Also, this segment is expected to grow at the highest CAGR in the forecast period. Various factors such as growing adoption of advanced hemostasis instruments and growing demand from emerging countries are driving the growth of this market.

Inquiry before Buying:http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=197226392

A number of factors such as the development of high-throughput hemostasis analyzers, increasing adoption of automated hemostasis instruments by diagnostic laboratories, technological advancements, and developments in high sensitivity point-of-care (POC) hemostasis testing are propelling the growth of the global coagulation analyzers market. On the other hand, slow adoption of advanced hemostasis instruments in emerging economies, and high cost of coagulation analyzers are restricting the growth of the global coagulation analyzers market.

Based on geography, the Global Coagulation Analyzers Market is dominated by North America, followed by Europe, Asia-Pacific, and the Rest of the World (RoW). North America is expected to account for the largest share of the market in 2014, while Asia-Pacific is likely to witness the highest growth in this market. A number of factors, including developing healthcare infrastructure, presence of a large patient population, increasing funding/investments towards the development of hemostasis products, and growing focus of both international and domestic players on emerging Asia-Pacific countries are stimulating the growth of the coagulation analyzers and reagents market in this region.

The key players in the Global Coagulation Analyzers Market include Sysmex Corporation (Japan), Siemens Healthcare (Germany), Roche Diagnostics (Switzerland), Instrumentation Laboratory Werfen Group (U.S.), Helena Laboratories (U.S.), Nihon Kohden Corporation (Nihon Kohden) (Japan), , International Technidyne Corporation (U.S.), Diagnostica Stago, Inc. (France), Alere, Inc. (U.S.), and Thermo Fisher Scientific, Inc. (U.S.), among others.

Browse Related Reports:

Hematology Analyzers & Reagents Market by Products (3-& 5- part hematology Analyzers, Point-of-Care, & Fully Automated), Consumables (Reagents & Stains), End Users (Research Institute, Hospital, & Clinical Testing Labs) - Global Forecasts to 2019

http://www.marketsandmarkets.com/Market-Reports/hematology-analyzers-reagents-market-153222146.html

Point-Of-Care Diagnostics / Testing Market by Products (Glucose Monitoring & Infectious Diseases Testing Kits, Cardiac & Tumor Markers), by End Users (Self & Professional Monitoring), Over the Counter & Prescription Based - Global Forecast to 2018

http://www.marketsandmarkets.com/Market-Reports/point-of-care-diagnostic-market-106829185.html

About MarketsandMarkets

MarketsandMarkets is world's No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.

M&M's flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Subscribe Reports from Healthcare Domain@http://www.marketsandmarkets.com/Subscription.html

Visit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare/medical-devices

Connect with us on LinkedIn @http://www.linkedin.com/company/marketsandmarkets

Contact:
Mr. Rohan
North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas, TX 75252
Tel: [phone]
E-mail: [e-mail]